{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:54:11Z","timestamp":1761512051572},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1999,3,1]],"date-time":"1999-03-01T00:00:00Z","timestamp":920246400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[1999,3]]},"DOI":"10.1007\/s10434-999-0200-7","type":"journal-article","created":{"date-parts":[[2005,2,25]],"date-time":"2005-02-25T23:51:49Z","timestamp":1109375509000},"page":"200-207","source":"Crossref","is-referenced-by-count":32,"title":["Estrogen Replacement Therapy and Breast Cancer: Analysis of Age of Onset and Tumor Characteristics"],"prefix":"10.1007","volume":"6","author":[{"given":"Malcolm M.","family":"Bilimoria","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Winchester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen F.","family":"Sener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Motykie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uday L.","family":"Sehgal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David P.","family":"Winchester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/canjclin.47.1.5","volume":"47","author":"SL Parker","year":"1997","unstructured":"Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. CA Cancer J Clin 1997;47:5?27.","journal-title":"CA Cancer J Clin"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3322\/canjclin.45.5.263","volume":"45","author":"MB Bilimoria","year":"1995","unstructured":"Bilimoria MB, Morrow M. Women at increased risk for breast cancer: evaluation and management strategies. CA Cancer J Clin 1995;45:263?78.","journal-title":"CA Cancer J Clin"},{"key":"CR3","first-page":"211","volume":"18","author":"M Morrow","year":"1993","unstructured":"Morrow M, Jordan VJ. Risk factors and the prevention of breast cancer with tamoxifen. Cancer Surv 1993;18:211?29.","journal-title":"Cancer Surv"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1001\/jama.1980.03300420019018","volume":"243","author":"RK Ross","year":"1980","unstructured":"Ross RK, Paginini-Hill A, Gerkins, et al. A case-control study of menopausal estrogen therapy and breast cancer. JAMA 1980;243:1635?9.","journal-title":"JAMA"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(97)08233-0","volume":"350","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"1997","unstructured":"Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997;350:1047?59.","journal-title":"Lancet"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1445-2197.1984.tb06677.x","volume":"55","author":"CW Elston","year":"1984","unstructured":"Elston CW. The assessment of histological differentiation in breast cancer. Aust N Z J Surg 1984;55:11?5.","journal-title":"Aust N Z J Surg"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1002\/1097-0142(19930915)72:6<1926::AID-CNCR2820720622>3.0.CO;2-I","volume":"72","author":"DE Merkel","year":"1993","unstructured":"Merkel DE, Winchester DJ, Goldschmidt RA, et al. DNA flow cytometry and pathologic grading as prognostic guides in axillary lymph node-negative breast Cancer. Cancer 1993;72:1926?32.","journal-title":"Cancer"},{"key":"CR8","first-page":"605","volume":"48","author":"D Trichopoulos","year":"1972","unstructured":"Trichopoulos D, MacMahon B, Cole P. Menopause and breast cancer risk. J Natl Cancer Inst 1972;48:605?13.","journal-title":"J Natl Cancer Inst"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/0091-7435(88)90056-4","volume":"17","author":"JC Mohle-Boetani","year":"1988","unstructured":"Mohle-Boetani JC, Grosser S, Whittemore AS, et al. Body size, reproductive factors, and breast cancer survival. Prev Med 1988;17:634?42.","journal-title":"Prev Med"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF01806526","volume":"13","author":"AW Lees","year":"1989","unstructured":"Lees AW, Jenkins JH, May CL, et al. Risk factors and 10-year breast cancer survival in Northern Alberta. Br Cancer Res Treat 1989;13:143?51.","journal-title":"Br Cancer Res Treat"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/bjc.1988.44","volume":"57","author":"TJA Key","year":"1988","unstructured":"Key TJA, Pike MC. The dose-effect relationship between unopposed oestrogens and endometrial mitotic rate: its central role in predicting endometrial cancer risk. Br J Cancer 1988;57:205?12.","journal-title":"Br J Cancer"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.5694\/j.1326-5377.1988.tb99424.x","volume":"148","author":"BK Armstrong","year":"1988","unstructured":"Armstrong BK. Oestrogen therapy after the menopause: boon or bane? Med J Aust 1988;148:213?4.","journal-title":"Med J Aust"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/archinte.1991.00400010089011","volume":"151","author":"WD Dupont","year":"1991","unstructured":"Dupont WD, Page DL. Menopausal estrogen replacement therapy and breast cancer. Arch Intern Med 1991;151:67?72.","journal-title":"Arch Intern Med"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/jama.1995.03530020055032","volume":"274","author":"JL Stanford","year":"1995","unstructured":"Stanford JL, Weiss NS, Voigt LF, et al. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA 1995;274:137?42.","journal-title":"JAMA"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/jama.1991.03460150089030","volume":"265","author":"KK Steinberg","year":"1991","unstructured":"Steinberg KK, Thacker SB, Smith SJ, et al. A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA 1991;265:1985?90.","journal-title":"JAMA"},{"key":"CR16","first-page":"286","volume":"79","author":"M Sillero-Arenas","year":"1992","unstructured":"Sillero-Arenas M, Delgado-Rodriguez M, Rodriguez-Canteras R, et al. Menopausal hormone replacement therapy and breast cancer: a meta-analysis. Obstet Gynecol 1992;79:286?94.","journal-title":"Obstet Gynecol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/S0002-9378(11)90784-4","volume":"168","author":"GA Colditz","year":"1993","unstructured":"Colditz GA, Egan KM, Stampfer MJ. Hormone replacement therapy and risk of breast cancer: results from epidemiologic studies. Am J Obstet Gynecol 1993;168:1473?80.","journal-title":"Am J Obstet Gynecol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00001648-199407000-00007","volume":"5","author":"KK Steinberg","year":"1994","unstructured":"Steinberg KK, Smith SJ, Thacker SB, et al. Breast cancer risk and duration of estrogen use: the role of study design in meta-analysis. Epidemiology 1994;5:415?21.","journal-title":"Epidemiology"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1001\/jama.1991.03460140052012","volume":"265","author":"WD Dupont","year":"1991","unstructured":"Dupont WD. Estrogen replacement therapy and risk of breast cancer. JAMA 1991;265:1824.","journal-title":"JAMA"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF01806152","volume":"38","author":"C Magnusson","year":"1996","unstructured":"Magnusson C, Holmberg L, Norden T, Lindgren A, Persson I. Prognostic characteristics in breast cancers after hormone replacement therapy. Breast Cancer Res Treat 1996;38:325?34.","journal-title":"Breast Cancer Res Treat"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/bjc.1986.246","volume":"54","author":"LA Brinton","year":"1986","unstructured":"Brinton LA, Hoover R, Fraumeni JF. Menopausal estrogens and breast cancer risk: an expanded case-control study. Br J Cancer 1986;54:825?32.","journal-title":"Br J Cancer"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1259\/0007-1285-68-814-1133","volume":"68","author":"CH Van Gils","year":"1995","unstructured":"Van Gils CH, Otten JDM, Verbeek ALM, et al. Breast parenchymal patterns and their changes with age. Br J Radiol 1995;68:1133?5.","journal-title":"Br J Radiol"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0009-9260(05)80566-5","volume":"43","author":"Z Kaufman","year":"1991","unstructured":"Kaufman Z, Garstin WIH, Hayes R, et al. The mammographic parenchymal patterns of women on hormone replacement therapy. Clin Radiol 1991;43:389?92.","journal-title":"Clin Radiol"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1148\/radiology.174.1.2152982","volume":"174","author":"JE Berkowitz","year":"1990","unstructured":"Berkowitz JE, Gatewood OMB, Goldblum LE, et al. Hormone replacement therapy: mammographic manifestations. Radiology 1990;174:199?201.","journal-title":"Radiology"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1148\/radiology.174.2.2136958","volume":"174","author":"PC Stomper","year":"1990","unstructured":"Stomper PC, Van Voorhid BJ, Ravnikar VA, et al. Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study. Radiology 1990;174:487?90.","journal-title":"Radiology"},{"key":"CR26","first-page":"1177","volume":"161","author":"D Cyrlak","year":"1993","unstructured":"Cyrlak D, Wong CH. Mammographic changes in postmenopausal women undergoing hormone replacement therapy. Am J Radiol 1993;161:1177?83.","journal-title":"Am J Radiol"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0009-9260(05)82914-9","volume":"49","author":"GJ Doyle","year":"1994","unstructured":"Doyle GJ, McLean L. Unilateral increase in mammographic density with hormone replacement therapy. Clin Radiol 1994;49:50?1.","journal-title":"Clin Radiol"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0009-9260(97)80053-0","volume":"52","author":"JC Litherland","year":"1997","unstructured":"Litherland JC, Evans AJ, Wilson AM. The effect of hormone replacement therapy on recall rate in the National Health Service Breast Screening Programme. Clin Radiol 1997;52:276?9.","journal-title":"Clin Radiol"},{"key":"CR29","first-page":"11","volume":"6","author":"A Tavani","year":"1997","unstructured":"Tavani A, Braga C, La Vecchia C, Negri E, Franceschi S. Hormone replacement treatment and breast cancer risk: an age-specific analysis. Cancer Epidemiol Biomarkers Prev 1997;6:11?4.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0140-6736(92)90997-H","volume":"339","author":"Early Breast Cancer Trialists? Collaborative Group","year":"1992","unstructured":"Early Breast Cancer Trialists? Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. I. Lancet 1992;339:1?15.","journal-title":"Lancet"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0140-6736(92)90997-H","volume":"339","author":"Early Breast Cancer Trialists? Collaborative Group","year":"1992","unstructured":"Early Breast Cancer Trialists? Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. II. Lancet 1992;339:71?85.","journal-title":"Lancet"},{"key":"CR32","first-page":"319","volume":"4","author":"JD Potter","year":"1993","unstructured":"Potter JD, Cerhan JR, Sellers TA, et al. Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women?s Health Study: how many different kinds of breast cancer are there? Cancer Epidemiol Rev 1993;4:319?26.","journal-title":"Cancer Epidemiol Rev"},{"key":"CR33","first-page":"1447","volume":"39","author":"JC Allegra","year":"1979","unstructured":"Allegra JC, Lippman ME, Thompson EB, et al. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer. Cancer Res 1979;39:1447?54.","journal-title":"Cancer Res"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1200\/JCO.1996.14.9.2584","volume":"14","author":"T Kuukasjarvi","year":"1996","unstructured":"Kuukasjarvi T, Kononen J, Helin H, et al. Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy. J Clin Oncol 1996;14:2584?9.","journal-title":"J Clin Oncol"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/(SICI)1097-0142(19961001)78:7<1403::AID-CNCR6>3.0.CO;2-L","volume":"78","author":"ER Fisher","year":"1996","unstructured":"Fisher ER, Costantino J, Fisher B, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17: five-year observations concerning lobular carcinoma in situ. Cancer 1996;78:1403?16.","journal-title":"Cancer"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0029-7844(94)00324-7","volume":"85","author":"P Bonnier","year":"1995","unstructured":"Bonnier P, Romain S, Giacalone PL, et al. Clinical and biologic prognostic factors in breast cancer diagnosed during postmenopausal hormone replacement therapy. Obstet Gynecol 1995;85:11?7.","journal-title":"Obstet Gynecol"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/BF01831376","volume":"5","author":"C Schairer","year":"1994","unstructured":"Schairer C, Byrne C, Keyl PM, et al. Menopausal estrogen and estrogen-progestin replacement therapy and risk of breast cancer. Cancer Causes Control 1994;5:491?500.","journal-title":"Cancer Causes Control"},{"key":"CR38","first-page":"167","volume":"178","author":"R Squitieri","year":"1994","unstructured":"Squitieri R, Tartter PI, Ahmed S, Brower ST, Theise ND. Carcinoma of the breast in postmenopausal hormone user and nonuser control groups. J Am Coll Surg 1994;178:167?70.","journal-title":"J Am Coll Surg"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJM199109123251102","volume":"325","author":"MJ Stampfer","year":"1991","unstructured":"Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurse?s Health Study. N Engl J Med 1991;325:756?62.","journal-title":"N Engl J Med"},{"key":"CR40","first-page":"159","volume":"19","author":"E Barrett-Connor","year":"1989","unstructured":"Barrett-Connor E, Bush TL. Estrogen replacement and coronary heart disease. Cardiovasc Clin 1989;19:159?72.","journal-title":"Cardiovasc Clin"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1056\/NEJM198711053171901","volume":"317","author":"DP Kiel","year":"1987","unstructured":"Kiel DP, Felson DT, Anerson JJ, et al. Hip fracture and the use of estrogens in postmenopausal women: the Framingham Study. N Engl J Med 1987;317:1169?74.","journal-title":"N Engl J Med"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1001\/jama.1997.03540380054031","volume":"277","author":"NF Col","year":"1997","unstructured":"Col NF, Eckman MH, Karas RH, et al. Patient-specific decisions about hormone replacement therapy in postmenopausal women. JAMA 1997;277:1140?7.","journal-title":"JAMA"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10434-999-0200-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10434-999-0200-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10434-999-0200-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T00:04:21Z","timestamp":1586131461000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10434-999-0200-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,3]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1999,3]]}},"alternative-id":["200"],"URL":"https:\/\/doi.org\/10.1007\/s10434-999-0200-7","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,3]]}}}